Funding Announcements
Funding Opportunities Specific to COVID-19 and the Behavioral and Social Sciences
The following is a list of recently released NOSIs for Urgent Competitive Revisions and Administrative Supplements encouraging COVID-19 behavioral and social sciences research. Key areas of research encouraged by these NOSIs include various aspects of the Novel Coronavirus (SARS-CoV-2) and COVID-19 including risk communication, adherence to and transmission risks from various public health mitigation efforts, economic and social impacts from these mitigation efforts, downstream health and healthcare access effects as a result of these economic and social impacts, and interventions to ameliorate these downstream health impacts. In addition to a number of NIH institute or center (IC) NOSIs, OBSSR also has issued a trans-NIH NOSI to address common areas of interest across ICs and provide a mechanism for ICs to fund urgent competitive revisions and administrative supplements without publishing their own NOSI.
To sort by title, organization, dates or announcement number, click the table headers below.
| Title | Announcement Number | Issuing Organization | Opening Date | Closing Date |
|---|
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | NOT-DA-20-047 | NIDA | 3/19/2020 | 3/31/2021 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences | NOT-OD-20-097 | OBSSR | 4/13/2020 | 4/1/2021 |
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus | NOT-MH-20-047 | NIMH | 3/27/2020 | 4/16/2021 |
| Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) | NOT-AG-20-022 | NIA | 4/6/2020 | 5/1/2021 |
| Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | NOT-GM-20-025 | NIGMS | 3/25/2020 | 2/6/2021 |
| Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) | NOT-AT-20-011 | NCCIH | 4/10/2020 | |
| Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA | NOT-AA-20-011 | NIAAA | 4/16/2020 | 4/16/2021 |
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities | NOT-MD-20-019 | NIMHD | 4/9/2020 | 5/1/2021 |
| Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) | PAR-20-237 | NIMHD | 7/28/2020 | 12/2/2020 |
| Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" | NOT-OD-20-103 | OppNet | 5/7/2020 | N/A |
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR | NOT-DE-20-022 | NIDCR | 5/5/2020 | N/A |
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) | NOT-ES-20-020 | NIEHS | 4/10/2020 | 5/4/2021 |
| Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 | NOT-MH-20-053 | NIMH | 6/5/2020 | 12/30/2020 |
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations | NOT-MD-20-022 | NIMHD | 6/5/2020 | 12/30/2020 |
| Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency | NOT-OD-20-118 | NIH | 6/10/2020 | N/A |
| Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | NOT-OD-20-121 | OD | 6/12/2020 | 8/8/2020 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | NOT-OD-20-120 | OD | 6/12/2020 | 9/9/2020 |
| Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations | NOT-OD-20-119 | OD | 6/12/2020 | 9/9/2020 |
| Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) | PAR-20-243 | NIMH | 7/20/2020 | 3/3/2021 |
OBSSR-Led FOAs
The Office of Behavioral and Social Sciences Research (OBSSR) participates in the following active funding announcements. Please note that this is not an exhaustive list of all funding announcements related to behavioral and social sciences research, but rather a list of those that OBSSR coordinates or has joined. OBSSR does not award grants. Please contact the NIH Institutes and Centers (IC) Research/Scientific contact(s) listed in these announcements for questions regarding IC funding interest in grant applications.
View the NIH Guide for Grants and Contracts for a complete list of all NIH funding announcements.
To sort by title, organization, dates or announcement number, click the table headers below.
OBSSR-Supported FOAs
The Office of Behavioral and Social Sciences Research (OBSSR) participates in the following active funding announcements. Please note that this is not an exhaustive list of all funding announcements related to behavioral and social sciences research, but rather a list of those that OBSSR coordinates or has joined. OBSSR does not award grants. Please contact the NIH Institutes and Centers (IC) Research/Scientific contact(s) listed in these announcements for questions regarding IC funding interest in grant applications.
View the NIH Guide for Grants and Contracts for a complete list of all NIH funding announcements.
To sort by title, organization, dates or announcement number, click the table headers below.
| Title | Announcement Number | Issuing Organization | Opening Date | Closing Date |
|---|
| Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) | PA-18-937 | NINDS | 1/5/2019 | 1/8/2022 |
| Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) | PA-18-939 | NINDS | 1/16/2019 | 1/8/2022 |
| BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required) | RFA-NS-19-001 | NINDS | 10/14/2018 | 10/20/2020 |
| BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (R21 Clinical Trial Required) | RFA-NS-19-002 | NINDS | 9/30/2018 | 10/31/2020 |
| BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (S21 Clinical Trial Not Allowed) | RFA-NS-19-003 | NINDS | 9/30/2018 | 10/31/2020 |
| Time-Sensitive Obesity Policy and Program Evaluation (N4 Clinical Trial Not Allowed) | PAR-18-854 | NIDDK | 7/23/2018 | 9/11/2021 |
| BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) | RFA-EB-20-002 | NIBIB | 8/14/2020 | 9/15/2021 |
| BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed) | RFA-EB-20-001 | NIBIB | 8/3/2020 | 9/4/2021 |
| BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed) | RFA-NS-18-030 | NINDS | 6/3/2018 | 11/11/2020 |
| BRAIN Initiative: Targeted BRAIN Circuits Planning Projects - TargetedBCPP (R34 Clinical Trial Not Allowed) | RFA-NS-18-014 | NINDS | 2/15/2018 | 11/10/2021 |
| NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed) | RFA-NS-19-011 | NIH Blueprint for Neuroscience Research | 11/13/2018 | 4/16/2021 |
| Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) | PA-18-943 | NINR | 1/16/2018 | 1/8/2022 |
| Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) | PA-18-944 | NINR | 1/5/2019 | 1/8/2022 |
| Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) | PA-18-945 | NINR | 1/5/2019 | 1/8/2022 |
| Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) | PA-18-946 | NINR | 1/16/2019 | 1/8/2022 |
| Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) | PAR-19-093 | NIMHD | 2/4/2019 | 3/5/2021 |
| Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) | PAR-19-212 | NIDA | 6/23/2019 | 3/24/2022 |
| Behavioral & Integrative Treatment Development Program (R34 Clinical Trial Optional) | PAR-19-213 | NIDA | 6/23/2019 | 3/24/2022 |
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) | PAR-19-200 | NCCIH | 5/5/2019 | 5/8/2022 |
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) | PAR-19-201 | NCCIH | 5/16/2019 | 5/8/2022 |
| Notice of Special Interest in Research on the Health of Sexual and Gender Minority (SGM) Populations | NOT-MD-19-001 | NIMHD | 3/13/2019 | N/A |
| Notice of Special Interest in Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development | NOT-DK-19-007 | NIDDK | 1/7/2019 | N/A |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-18-589 | NCI | 1/26/2018 | 1/26/2021 |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) | PA-18-591 | NCI | 1/25/2018 | 1/26/2021 |
| Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) | PA-18-590 | NCI | 1/26/2018 | 1/26/2021 |
| BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) | RFA-MH-20-120 | NIMH | 8/6/2019 | 2/27/2021 |
| Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) | PAR-19-274 | NCI | 5/8/2019 | 5/8/2022 |
| Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) | PAR-19-275 | NCI | 5/16/2019 | 5/8/2022 |
| Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) | PAR-19-276 | NCI | 5/16/2019 | 5/8/2022 |
| Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed) | PAR-19-249 | NIA | 6/8/2019 | 3/9/2021 |
| Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Populations (R01 Clinical Trial Optional) | PAR-19-250 | NIEHS | 6/8/2019 | 3/9/2021 |
| Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) | PAR-19-384 | NIH | 2/17/2020 | 3/18/2021 |
| Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) | PAR-19-376 | FIC | 10/19/2019 | 12/4/2020 |
| Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) | PAR-19-373 | NIH | 2/17/2020 | 3/18/2021 |
| Notice of Special Interest: Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp Clinical Trial Optional) | NOT-OD-20-032 | NIH | 12/6/2019 | 1/26/2021 |
| Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards | NOT-OD-20-055 | NIH | 1/17/2020 | 3/6/2023 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) | PAR-20-111 | NINDS | 3/2/2020 | 5/8/2023 |
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | PAR-20-122 | NINDS | 3/3/2020 | 5/8/2023 |
| BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed) | RFA-MH-20-128 | NIMH | 8/3/2020 | 9/3/2021 |
| Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) | NOT-MD-20-011 | NIMHD | 3/27/2020 | 9/8/2022 |
| BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional) | RFA-NS-20-029 | NINDS | 6/14/2020 | 6/16/2021 |
| Notice of Special Interest: Ancillary Reproductive Health Projects to Existing Large and/or Longitudinal Studies | NOT-HD-20-008 | NICHD | 4/6/2020 | 5/2/2022 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) | PAR-20-168 | NINDS | 4/13/2020 | 5/8/2023 |
| Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) | PAR-20-165 | NINDS | 5/5/2020 | 3/6/2023 |
| Notice of Special Interest (NOSI): Implementation of Clinical Care Guidelines on Opioid Prescribing for Pain Management | NOT-DA-20-038 | NIDA | 4/27/2020 | 1/8/2023 |
| Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) | PAR-20-180 | ODP | 4/30/2020 | 9/8/2023 |
| Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials) | PAR-20-211 | OppNet | 2/16/2021 | 3/18/2023 |
| Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) | PAR-20-226 | OppNet | 2/16/2021 | 3/18/2023 |
| Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) | RFA-OD-20-013 | OD | 7/8/2020 | 8/8/2020 |
| Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional) | RFA-DA-21-009 | NIDA | 9/19/2020 | 10/20/2020 |
